Air Global

Reinvestment: Management has deployed over 125 million dollars into next‑generation categories since FY2019 and recently committed 20 million dollars to Greentank with an option to increase the stake, positioning for a U.S. Crown Switch entry pending PMTA outcomes.

These investments are strategic but currently loss‑making (NGC adjusted EBITDA was a loss in H1 2026). Buybacks: The EGM authorized and approved a specific 5 million‑share Harraden repurchase at 10.49 dollars and broader repurchase authorities, suggesting willingness to adjust capital structure.

Balance: Given net leverage in the low‑2x range and a capex‑light core, prudent repurchases below intrinsic value and disciplined NGC spend are appropriate. Watch stock‑based compensation and earn‑outs (about 8.69 million shares subject to price‑based vesting) for dilution.

Overall, a mixed but improving record: clear strategic logic, but the return on NGC and timing of U.S. approvals remain to be proven.